P540: PEVONEDISTAT, AZACITIDINE AND VENETOCLAX FOR PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA– A PHASE I STUDY

• G. S. Guru Murthy,
• S. Kaufmann,
• A. Saliba,
• A. Szabo,
• L. Michaelis,
• S. Abedin,
• L. Runaas,
• K. Carlson,
• S. Maldonado-Schmidt,
• A. Hinman,
• A. Thomas,
• A. Baim,
• M. Litzow,
• E. Atallah

Affiliations

G. S. Guru Murthy

1 Hematology-Oncology, Medical College of Wisconsin, Milwaukee

S. Kaufmann

2 Hematology-Oncology, Mayo Clinic, Rochester

A. Saliba

2 Hematology-Oncology, Mayo Clinic, Rochester

A. Szabo

3 Biostatistics

L. Michaelis

1 Hematology-Oncology, Medical College of Wisconsin, Milwaukee

S. Abedin

1 Hematology-Oncology, Medical College of Wisconsin, Milwaukee

L. Runaas

1 Hematology-Oncology, Medical College of Wisconsin, Milwaukee

K. Carlson

1 Hematology-Oncology, Medical College of Wisconsin, Milwaukee

S. Maldonado-Schmidt

4 Clinical trials, Hematology-Oncology, Medical College of Wisconsin, Milwaukee, United States of America

A. Hinman

4 Clinical trials, Hematology-Oncology, Medical College of Wisconsin, Milwaukee, United States of America

A. Thomas

4 Clinical trials, Hematology-Oncology, Medical College of Wisconsin, Milwaukee, United States of America

A. Baim

4 Clinical trials, Hematology-Oncology, Medical College of Wisconsin, Milwaukee, United States of America

M. Litzow

2 Hematology-Oncology, Mayo Clinic, Rochester

E. Atallah

1 Hematology-Oncology, Medical College of Wisconsin, Milwaukee